KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer.
Suzuki T, Masugi Y, Inoue Y, Hamada T, Tanaka M, Takamatsu M, Arita J, Kato T, Kawaguchi Y, Kunita A, Nakai Y, Nakano Y, Ono Y, Sasahira N, Takeda T, Tateishi K, Uemura S, Koike K, Ushiku T, Takeuchi K, Sakamoto M, Hasegawa K, Kitago M, Takahashi Y, Fujishiro M; GTK Pancreatic Cancer Study Group in Japan.
Suzuki T, et al. Among authors: takamatsu m.
Cancer Sci. 2022 Sep;113(9):3097-3109. doi: 10.1111/cas.15398. Epub 2022 Jun 12.
Cancer Sci. 2022.
PMID: 35567350
Free PMC article.